Compare Medpace Holdings Inc (MEDP) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Riot Platforms Inc — how do they compare? Medpace Holdings Inc trades at $533.39 (market cap $15.08B), while Riot Platforms Inc trades at $21.75 (market cap $7.53B). The key difference: Medpace Holdings Inc is far larger — about 2× Riot Platforms Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | RIOT | |
|---|---|---|
Market Cap | $15.08B | $7.53B |
Sector | Technology | Technology |
52-Week High | $620.59 | $28.67 |
52-Week Low | $308.88 | $11.03 |
Enterprise Value | $14.55B | $8.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
RIOT trades at $19.90, up 8.98% today but facing bearish technical signals with the stock trading below key resistance levels. The company reported a net loss of $663.18 million in 2025 with negative profit margins, though revenue reached $647.44 million. Analyst consensus remains overwhelmingly bullish with 94% buy ratings and a $27.86 price target, representing 40% upside potential from current levels.
While Wall Street maintains strong buy recommendations, RIOT faces significant fundamental challenges with persistent losses and negative cash flow from operations. The stock's investment case hinges on successful execution of the company's strategic pivot toward high-performance computing and data center expansion, though operational losses and competitive pressures present substantial risks to shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
